Lifeward (LFWD) Income from Continuing Operations (2015 - 2026)
Lifeward (LFWD) posted Income from Continuing Operations of 10793000.0 for Q1 2026, down 101.81% sequentially from 5348000.0 in Q4 2025, and down 123.27% YoY from 46376321.78 in Q1 2025.
Lifeward (LFWD) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Lifeward has reported Income from Continuing Operations for 12 years, with the latest figure at 10793000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 123.27% year-over-year to 10793000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25873000.0 (up 5.92% YoY) and the FY2025 annual result came in at 19914000.0, up 31.19% from the prior year.
- Income from Continuing Operations slipped to 10793000.0 in Q1 2026 per LFWD's latest filing, from 5348000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 3084000.0 in Q3 2024 and troughed at 15278000.0 in Q4 2024.
- A 5-year average of 5961823.53 and a median of 5313000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations sank 170.93% in 2024, then soared 65.0% in 2025.
- Over 5 years, Income from Continuing Operations stood at 5313000.0 in 2022, then declined by 6.14% to 5639000.0 in 2023, then tumbled by 170.93% to 15278000.0 in 2024, then jumped by 65.0% to 5348000.0 in 2025, then plunged by 101.81% to 10793000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 10793000.0, 5348000.0, and 3170000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Lifeward | 20.39 Mn | 10.94 Mn | 2.71 Mn | -11.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.79 Mn |
| Dec 31, 2025 | -5.35 Mn |
| Sep 30, 2025 | -3.17 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Mar 31, 2025 | -4.83 Mn |
| Dec 31, 2024 | -15.28 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Mar 31, 2024 | -6.28 Mn |
| Dec 31, 2023 | -5.64 Mn |
| Sep 30, 2023 | -7.53 Mn |
| Jun 30, 2023 | -4.64 Mn |
| Mar 31, 2023 | -4.32 Mn |
| Dec 31, 2022 | -5.31 Mn |
| Sep 30, 2022 | -5.46 Mn |
| Jun 30, 2022 | -4.45 Mn |
| Mar 31, 2022 | -4.35 Mn |
| Dec 31, 2021 | -3.86 Mn |
| Sep 30, 2021 | -2.68 Mn |
| Jun 30, 2021 | -3.14 Mn |